BriaCell Therapeutics Corp. BCTX
3.06 USD -0.10 (-3.32%)
Regular-session close
3.10 +0.04 +1.31%
After hours · Nov 20, 5:59 PM ET
3.02 Day range 3.20
2.74 52-week range 12.64
- YTD
- -56.96%
- 1 year
- -56.41%
BCTX revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2026 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2026 | 2026-07-31 | 0 | 0 | Not meaningful |
| FY 2025 | 2025-07-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-07-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-07-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-07-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-07-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-07-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-07-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-07-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-30T05:30:02.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
